NPS Pharmaceuticals, Inc. (NPSP) Reports Change In Tentative Date Of FDA Advisory Committee Review Of Natpara® BLA To September 12 - PDUFA Date Of October 24 Remains Unchanged
6/10/2014 10:01:37 AM
BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today reported that the U.S. Food and Drug Administration (FDA) shifted the tentative date for the Natpara® (rhPTH[1-84]) Advisory Committee Meeting from July 24 to September 12, 2014. A definitive date for the advisory committee meeting is expected to be published by FDA in the Federal Register at least 15 days prior to such meeting. The Prescription Drug User Fee Act (PDUFA) Action Date of October 24, 2014 remains unchanged.
Help employers find you! Check out all the jobs and post your resume.
comments powered by